Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Karydas Daphne sold 3,000 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Karydas Daphne (Director) sold 3,000 Mineralys Therapeutics, Inc. shares at US$28.58 for US$85,740 under a trading plan, leaving 6,200 shares. Filed Sep 17, 2026 (Form 4).
- Sold
- 3,000 shares
- Price
- US$28.58
- Value
- US$85,740
- Holding after
- 6,200 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Option exercise | 3,000 | US$12.02 | 9,200 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 3,000 | US$28.58 | 6,200 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Karydas Daphne
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Karydas Daphne · Jun 17, 2026
- Form 4 · Karydas Daphne · Apr 2, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026
- Form 4 · Warren Eric · Aug 25, 2026
- Form 4 · Ferguson James J. III · Aug 12, 2026